thiophenes has been researched along with Malabsorption Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, N; Ogawa, T; Oyama, G | 1 |
| Bryant, S; De Jonghe, S; Feyen, B; Johnson, MD; Kelley, MF; Lammens, G; Louden, C; Ma, JY; Mamidi, RN; Moesen, E; Proctor, J; Snook, S; Vinken, P; Ways, K | 1 |
| Block, F; Dafotakis, M; Juzek, A; Kosinski, CM; Sparing, R | 1 |
3 other study(ies) available for thiophenes and Malabsorption Syndromes
| Article | Year |
|---|---|
Transdermal rotigotine patch in Parkinson's disease with a history of intestinal operation.
Topics: Adult; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Intestine, Small; Malabsorption Syndromes; Male; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2018 |
Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin.
Topics: Animals; Canagliflozin; Carbohydrate Metabolism, Inborn Errors; Carcinogenesis; Cell Adhesion Molecules; Cell Proliferation; Glucosides; Immunohistochemistry; Kidney; Malabsorption Syndromes; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis.
Topics: Administration, Cutaneous; Dopamine Agonists; Fear; Humans; Malabsorption Syndromes; Male; Middle Aged; Parkinsonian Disorders; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes | 2009 |